# Pregabalin Trial In HIV Neuropathic Pain

> **NCT01145417** · PHASE3 · TERMINATED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 217 (actual)

## Conditions studied

- HIV-1 Infection
- Neuropathic Pain

## Interventions

- **DRUG:** pregabalin (Lyrica)

## Key facts

- **NCT ID:** NCT01145417
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-07
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 217 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2021-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01145417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01145417, "Pregabalin Trial In HIV Neuropathic Pain". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT01145417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*